Trevi Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Trevi Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Trevi Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Trevi Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $5.6M | 1.0M | 5.47 |
| 2024-12-31 | $786k | 191k | 4.12 |
| 2024-09-30 | $663k | 199k | 3.34 |
| 2024-06-30 | $265k | 89k | 2.98 |
| 2024-03-31 | $235k | 68k | 3.45 |
| 2023-12-31 | $200k | 149k | 1.34 |
| 2023-09-30 | $76k | 35k | 2.18 |
| 2023-06-30 | $90k | 38k | 2.39 |
| 2022-12-31 | $878 | 439 | 2.00 |
| 2022-03-31 | $1.0k | 589 | 1.70 |
| 2019-09-30 | $999 | 114 | 8.77 |